New Class Of Weight-Loss Drugs May Have Fewer Side Effects Than GLP-1s

Дата публикации: 05-10-2026 10:10:29

MONDAY, Oct. 5, 2026 — An emerging class of weight-loss medications helps users shed pounds but with a much lower risk for gastrointestinal side effects compared to popular GLP-1s, researchers report.
The weekly injected medications are...

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Limiting Weight Regain After GLP-1s: Two Strategies Show Promise	0	11.25	07-10-2026
2	expert reaction to trial of new amylin-based weight-loss drug petrelintide, noting fewer side effects than GLP-1-based drugs	0	13.3	29-09-2026
3	GLP-1 Use Surging Among New Mothers	0	15.44	02-10-2026
4	STAT+: Once described as obesity medicines for ‘patients,’ GLP-1s are increasingly lifestyle drugs for ‘customers’	0	7.79	28-09-2026
5	STAT+: Pharmalittle: We’re reading about GLP-1s becoming lifestyle drugs, a setback for Merck and Daiichi, and more	0	6.55	28-09-2026
6	Menos ultraprocesados y más fruta: así comen ahora los usuarios de fármacos para perder peso	0	6.64	29-09-2026
7	Taking a GLP-1 and feeling alone? You’re not; a South Carolina resort offers support	0	10.12	28-09-2026
8	Are GLP-1 users eating out less, or just ordering less?	0	10.87	05-10-2026
9	Daily oral GLP-1 medication linked to similar weight loss across three menopausal stages	0	7.03	26-09-2026
10	Speaker: GLP-1s may be anti-inflammatory ‘even without obesity’	0	10.61	20-09-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 14.41. Источник: www.drugs.com.